The global therapeutic respiratory devices market size was exhibited at USD 20.05 billion in 2022 and is projected to hit around USD 36.29 billion by 2032, growing at a CAGR of 4.02% during the forecast period 2023 to 2032.
Key Pointers:
Therapeutic Respiratory Devices Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 21.28 Billion |
Market Size by 2032 | USD 36.29 Billion |
Growth Rate From 2023 to 2032 | CAGR of 4.02% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Product type, Technology, Filter |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key Companies Profiled | GE Healthcare; Koninklijke Philips N.V.; ICU Medical (Smiths Medical); Invacare Corporation; Medtronic; Fisher & Paykel Healthcare; ResMed; Linde; Mindray; Chart Industries; Drägerwerk AG & Co. KGaA; DeVilbiss Healthcare |
Therapeutic respiratory devices are primarily used in therapeutics for improvising pulmonary functionalities by clearing the airway, enhancing lung oxygen intake capacities and providing assistance for mucous removal from bronchi during respiratory therapeutics treatment. These respiratory devices are also utilized for assistance in the treatment of various chronic ailments associated with respiratory malfunction. These ailments include the likes of chronic obstructive pulmonary disease (COPD), bronchitis, sleep disorders, asthma and other chronic diseases. Availability of these devices in the market include variable types with slight difference in the application purpose such as long-term respiratory devices used mainly for intensive care, mobile home respiratory devices to be applied in homecare settings and portable respiratory devices to be utilized during emergency for providing point of care assistance. Owing to wide variety of application, these equipment are also implemented if facilitating and improvising respiratory function in infants during post natal care, specifically among the preterm births, post-partum complications and associated conditions.
The increasing patient pool owing to the rising prevalence of chronic disorders causing disturbance in the normal functioning of respiration will be a key driver for the development of therapeutic respiratory devices business growth. According to the Forum of International Respiratory Societies (FIRS) research, approximately, the number of people suffering from sleep breathing disorders in around 100 million, those suffering with asthma is over 235 million people and the number of people diagnosed with COPD reportedly is around 200 million. Factors such as high levels of air pollution, exposures to various toxic chemicals and gases, chain smoking of tobacco causing obstruction of the airway passage for responsible for rising prevalence of respiratory infections in developing as well of developed regions. These factors would ensure the growth of this therapeutic respiratory devices market in the near future.
Some of the prominent players in the Therapeutic Respiratory Devices Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Therapeutic Respiratory Devices market.
By Product Type
By Technology
By Filter
By Region